Over 150 North Carolina Auctions End Tomorrow 11/29 - Bid Now Over 2300 Total Lots Up For Auction at Two Locations - NJ 11/30, CA 12/04 Visit DOTmed at RSNA 2023 - Booth #6804, North Hall B - Meet the DOTmed Team
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Insight, Inc., a leading U.S. developer of wearable biosensors and diagnostic software systems featuring proprietary automated data analysis algorithms, announced today that its wearable ECG Sensor, Cardea SOLO, continues to attract high-volume cardiology group practices across the U.S. The company unveiled Baltimore Heart Associates of Maryland and Regional Cardiac Arrhythmia of Pennsylvania and Ohio as two of its newest multi-location practice customers. Cardiac Insight also announced the company is experiencing steady month-to-month sales growth and increases in repeat orders for Cardea SOLO in its targeted markets across the country.
Both cardiology groups selected Cardea SOLO for its unique ability to provide a higher standard of ambulatory cardiac care, improved operational and financial metrics for their practices, and positive patient experiences.
“Baltimore Heart Associates is recognized for its unique ability to provide the highest standard of patient care and operational efficiency while serving the greater Baltimore area with our seven cardiologists and three office locations. Our adoption of industry-first Cardea SOLO supports our mission to bring cutting-edge technology and quality-driven care to our patients,” said Mohammed Abuzahra, MD FACC. “Cardea SOLO is patient-friendly and an easy-to-use system. Once ordered by one of our prescribing clinicians, the device is applied to the patient and seven days later the patient returns to have the ECG data analyzed right in our office—it’s that simple.”
“Cardea SOLO brings a much needed ‘sea change’ to ambulatory arrhythmia detection,” added Maninder Bedi, MD, a clinical cardiac electrophysiologist with Regional Cardiac Arrhythmia of Washington, Pennsylvania. “Adoption was painless and Cardea SOLO’s design made it easy to integrate into our clinical workflow. Our patients love the comfort and freedom of the cable-free chest-worn form factor, and we enjoy the immediate access to complete ECG data whenever we want it. Our office controls the entire process so that we can offer the highest quality of service and patient care.”
“Cardiac Insight is experiencing outstanding momentum in all areas of the business, and our continued sales trajectory combined with growing reorders affirms that our technology solutions align with the needs of practitioners and their patients, as shown by the adoption from these prestigious institutions,” said Brad Harlow, Chief Executive Officer. “Our company and technology continue to raise the bar for frontline cardiac care, while helping to save lives and optimize healthcare operations. Our Cardea SOLO brings exclusive and proprietary capabilities to our customers that no other wearable cardiac monitoring technology can offer.”